-->
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. MARKET SEGMENTATION AND SCOPE
1.2. MARKET DEFINITIONS
1.2.1. TYPE
1.2.2. APPLICATION
1.2.3. END-USE
1.3. INFORMATION ANALYSIS
1.4. MARKET FORMULATION & DATA VISUALIZATION
1.5. DATA VALIDATION & PUBLISHING
1.6. INFORMATION PROCUREMENT
1.6.1. PRIMARY RESEARCH
1.7. INFORMATION OR DATA ANALYSIS
1.8. MARKET FORMULATION & VALIDATION
1.9. MARKET MODEL
1.10. OBJECTIVES
CHAPTER 2. EXECUTIVE SUMMARY
2.1. MARKET OUTLOOK
2.2. SEGMENT SNAPSHOT
2.3. COMPETITIVE LANDSCAPE SNAPSHOT
CHAPTER 3. MARKET VARIABLES, TRENDS, & SCOPE
3.1. MARKET LINEAGE OUTLOOK
3.1.1. PARENT MARKET OUTLOOK
3.1.2. RELATED/ANCILLARY MARKET OUTLOOK
3.2. MARKET DYNAMICS
3.2.1. MARKET DRIVER ANALYSIS
3.2.1.1. GROWTH OF OLIGONUCLEOTIDE THERAPIES
3.2.1.2. ADVANCEMENTS IN GENOMICS AND PERSONALIZED MEDICINE
3.2.1.3. GROWTH IN SYNTHETIC BIOLOGY RESEARCH
3.2.2. MARKET RESTRAINT ANALYSIS
3.2.2.1. STRINGENT REGULATIONS FOR OLIGONUCLEOTIDE THERAPIES
3.2.2.2. DIFFICULTIES IN LONG CHAIN SYNTHESIS
3.3. INDUSTRY ANALYSIS TOOLS
3.3.1. PORTER'S FIVE FORCES ANALYSIS
3.3.2. PESTEL ANALYSIS
3.3.3. COVID-19 IMPACT ANALYSIS
CHAPTER 4. PHOSPHORAMIDITE MARKET: TYPE BUSINESS ANALYSIS
4.1. TYPE SEGMENT DASHBOARD
4.2. GLOBAL PHOSPHORAMIDITE MARKET TYPE MOVEMENT ANALYSIS
4.3. GLOBAL PHOSPHORAMIDITE MARKET SIZE & TREND ANALYSIS, BY TYPE, 2024 TO 2033
4.4. DNA PHOSPHORAMIDITES
4.4.1. GLOBAL DNA PHOSPHORAMIDITES MARKET ESTIMATES AND FORECASTS, 2025 - 2033
4.5. RNA PHOSPHORAMIDITES
4.5.1. GLOBAL RNA PHOSPHORAMIDITES MARKET ESTIMATES AND FORECASTS, 2025 - 2033
4.6. LABELED PHOSPHORAMIDITES
4.6.1. GLOBAL LABELED PHOSPHORAMIDITES MARKET ESTIMATES AND FORECASTS, 2025 - 2033
4.7. MODIFIER PHOSPHORAMIDITES
4.7.1. GLOBAL MODIFIER PHOSPHORAMIDITES MARKET ESTIMATES AND FORECASTS, 2025 - 2033
4.8. OTHERS
4.8.1. GLOBAL OTHERS MARKET ESTIMATES AND FORECASTS, 2025 - 2033
CHAPTER 5. PHOSPHORAMIDITE MARKET: APPLICATION BUSINESS ANALYSIS
5.1. APPLICATION SEGMENT DASHBOARD
5.2. GLOBAL PHOSPHORAMIDITE MARKET APPLICATION, MOVEMENT ANALYSIS
5.3. GLOBAL PHOSPHORAMIDITE MARKET SIZE & TREND ANALYSIS, BY APPLICATION, 2024 TO 2033
5.4. DRUG DISCOVERY & DEVELOPMENT
5.4.1. GLOBAL DRUG DISCOVERY & DEVELOPMENTMARKET ESTIMATES AND FORECASTS, 2025 - 2033
5.5. DIAGNOSTICS DEVELOPMENT
5.5.1. GLOBAL DIAGNOSTICS DEVELOPMENT MARKET ESTIMATES AND FORECASTS, 2025 - 2033
5.6. OTHERS
5.6.1. GLOBAL OTHERS MARKET ESTIMATES AND FORECASTS, 2025 - 2033
CHAPTER 6. PHOSPHORAMIDITE MARKET: END-USE BUSINESS ANALYSIS
6.1. END-USE SEGMENT DASHBOARD
6.2. GLOBAL PHOSPHORAMIDITE MARKET END-USE MOVEMENT ANALYSIS
6.3. GLOBAL PHOSPHORAMIDITE MARKET SIZE & TREND ANALYSIS, BY END-USE, 2024 TO 2033
6.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
6.4.1. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET ESTIMATES AND FORECASTS, 2025 - 2033
6.5. ACADEMIC & RESEARCH INSTITUTES
6.5.1. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET ESTIMATES AND FORECASTS, 2025 - 2033
6.6. OTHERS
6.6.1. GLOBAL OTHERS MARKET ESTIMATES AND FORECASTS, 2025 - 2033
CHAPTER 7. PHOSPHORAMIDITE MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. REGIONAL DASHBOARD
7.2. MARKET SIZE & FORECASTS AND TREND ANALYSIS, 2018 TO 2030
7.3. NORTH AMERICA
7.3.1. NORTH AMERICA PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.3.2. U.S.
7.3.2.1. KEY COUNTRY DYNAMICS
7.3.2.2. COMPETITIVE SCENARIO
7.3.2.3. REGULATORY FRAMEWORK
7.3.2.4. U.S. PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.3.3. CANADA
7.3.3.1. KEY COUNTRY DYNAMICS
7.3.3.2. COMPETITIVE SCENARIO
7.3.3.3. REGULATORY FRAMEWORK
7.3.3.4. CANADA PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.3.4. MEXICO
7.3.4.1. KEY COUNTRY DYNAMICS
7.3.4.2. COMPETITIVE SCENARIO
7.3.4.3. REGULATORY FRAMEWORK
7.3.4.4. MEXICO PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.4. EUROPE
7.4.1. EUROPE PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.4.2. UK
7.4.2.1. KEY COUNTRY DYNAMICS
7.4.2.2. COMPETITIVE SCENARIO
7.4.2.3. REGULATORY FRAMEWORK
7.4.2.4. UK PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.4.3. GERMANY
7.4.3.1. KEY COUNTRY DYNAMICS
7.4.3.2. COMPETITIVE SCENARIO
7.4.3.3. REGULATORY FRAMEWORK
7.4.3.4. GERMANY PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.4.4. FRANCE
7.4.4.1. KEY COUNTRY DYNAMICS
7.4.4.2. COMPETITIVE SCENARIO
7.4.4.3. REGULATORY FRAMEWORK
7.4.4.4. FRANCE PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.4.5. ITALY
7.4.5.1. KEY COUNTRY DYNAMICS
7.4.5.2. COMPETITIVE SCENARIO
7.4.5.3. REGULATORY FRAMEWORK
7.4.5.4. ITALY PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.4.6. SPAIN
7.4.6.1. KEY COUNTRY DYNAMICS
7.4.6.2. COMPETITIVE SCENARIO
7.4.6.3. REGULATORY FRAMEWORK
7.4.6.4. SPAIN PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.4.7. DENMARK
7.4.7.1. KEY COUNTRY DYNAMICS
7.4.7.2. COMPETITIVE SCENARIO
7.4.7.3. REGULATORY FRAMEWORK
7.4.7.4. DENMARK PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.4.8. SWEDEN
7.4.8.1. KEY COUNTRY DYNAMICS
7.4.8.2. COMPETITIVE SCENARIO
7.4.8.3. REGULATORY FRAMEWORK
7.4.8.4. SWEDEN PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.4.9. NORWAY
7.4.9.1. KEY COUNTRY DYNAMICS
7.4.9.2. COMPETITIVE SCENARIO
7.4.9.3. REGULATORY FRAMEWORK
7.4.9.4. NORWAY PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.5. ASIA PACIFIC
7.5.1. ASIA PACIFIC PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.5.2. JAPAN
7.5.2.1. KEY COUNTRY DYNAMICS
7.5.2.2. COMPETITIVE SCENARIO
7.5.2.3. REGULATORY FRAMEWORK
7.5.2.4. JAPAN PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.5.3. CHINA
7.5.3.1. KEY COUNTRY DYNAMICS
7.5.3.2. COMPETITIVE SCENARIO
7.5.3.3. REGULATORY FRAMEWORK
7.5.3.4. CHINA PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.5.4. INDIA
7.5.4.1. KEY COUNTRY DYNAMICS
7.5.4.2. COMPETITIVE SCENARIO
7.5.4.3. REGULATORY FRAMEWORK
7.5.4.4. INDIA PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.5.5. AUSTRALIA
7.5.5.1. KEY COUNTRY DYNAMICS
7.5.5.2. COMPETITIVE SCENARIO
7.5.5.3. REGULATORY FRAMEWORK
7.5.5.4. AUSTRALIA PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.5.6. THAILAND
7.5.6.1. KEY COUNTRY DYNAMICS
7.5.6.2. COMPETITIVE SCENARIO
7.5.6.3. REGULATORY FRAMEWORK
7.5.6.4. THAILAND PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.5.7. SOUTH KOREA
7.5.7.1. KEY COUNTRY DYNAMICS
7.5.7.2. COMPETITIVE SCENARIO
7.5.7.3. REGULATORY FRAMEWORK
7.5.7.4. SOUTH KOREA PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.6. LATIN AMERICA
7.6.1. LATIN AMERICA PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.6.2. BRAZIL
7.6.2.1. KEY COUNTRY DYNAMICS
7.6.2.2. COMPETITIVE SCENARIO
7.6.2.3. REGULATORY FRAMEWORK
7.6.2.4. BRAZIL PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.6.3. ARGENTINA
7.6.3.1. KEY COUNTRY DYNAMICS
7.6.3.2. COMPETITIVE SCENARIO
7.6.3.3. REGULATORY FRAMEWORK
7.6.3.4. ARGENTINA PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.7. MEA
7.7.1. MEA PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.7.2. SOUTH AFRICA
7.7.2.1. KEY COUNTRY DYNAMICS
7.7.2.2. COMPETITIVE SCENARIO
7.7.2.3. REGULATORY FRAMEWORK
7.7.2.4. SOUTH AFRICA PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.7.3. SAUDI ARABIA
7.7.3.1. KEY COUNTRY DYNAMICS
7.7.3.2. COMPETITIVE SCENARIO
7.7.3.3. REGULATORY FRAMEWORK
7.7.3.4. SAUDI ARABIA PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.7.4. UAE
7.7.4.1. KEY COUNTRY DYNAMICS
7.7.4.2. COMPETITIVE SCENARIO
7.7.4.3. REGULATORY FRAMEWORK
7.7.4.4. UAE PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.7.5. KUWAIT
7.7.5.1. KEY COUNTRY DYNAMICS
7.7.5.2. COMPETITIVE SCENARIO
7.7.5.3. REGULATORY FRAMEWORK
7.7.5.4. KUWAIT PHOSPHORAMIDITE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. PARTICIPANT CATEGORIZATION
8.2. STRATEGY MAPPING
8.3. COMPANY MARKET POSITION ANALYSIS, 2023
8.4. PARTICIPANT’S OVERVIEW
8.4.1. BOC SCIENCES
8.4.1.1. OVERVIEW
8.4.1.2. FINANCIAL PERFORMANCE
8.4.1.3. PRODUCT BENCHMARKING
8.4.1.4. STRATEGIC INITIATIVES
8.4.2. THERMO FISHER SCIENTIFIC INC.
8.4.2.1. OVERVIEW
8.4.2.2. FINANCIAL PERFORMANCE
8.4.2.3. PRODUCT BENCHMARKING
8.4.2.4. STRATEGIC INITIATIVES
8.4.3. MERCK KGAA
8.4.3.1. OVERVIEW
8.4.3.2. FINANCIAL PERFORMANCE
8.4.3.3. PRODUCT BENCHMARKING
8.4.3.4. STRATEGIC INITIATIVES
8.4.4. GLEN RESEARCH
8.4.4.1. OVERVIEW
8.4.4.2. FINANCIAL PERFORMANCE
8.4.4.3. PRODUCT BENCHMARKING
8.4.4.4. STRATEGIC INITIATIVES
8.4.5. LGC BIOSEARCH TECHNOLOGIES
8.4.5.1. OVERVIEW
8.4.5.2. FINANCIAL PERFORMANCE
8.4.5.3. PRODUCT BENCHMARKING
8.4.5.4. STRATEGIC INITIATIVES
8.4.6. BIOSYNTH
8.4.6.1. OVERVIEW
8.4.6.2. FINANCIAL PERFORMANCE
8.4.6.3. PRODUCT BENCHMARKING
8.4.6.4. STRATEGIC INITIATIVES
8.4.7. BIONEER CORPORATION
8.4.7.1. OVERVIEW
8.4.7.2. FINANCIAL PERFORMANCE
8.4.7.3. PRODUCT BENCHMARKING
8.4.7.4. STRATEGIC INITIATIVES
8.4.8. QIAGEN
8.4.8.1. OVERVIEW
8.4.8.2. FINANCIAL PERFORMANCE
8.4.8.3. PRODUCT BENCHMARKING
8.4.8.4. STRATEGIC INITIATIVES
8.4.9. POLYORG, INC
8.4.9.1. OVERVIEW
8.4.9.2. FINANCIAL PERFORMANCE
8.4.9.3. PRODUCT BENCHMARKING
8.4.9.4. STRATEGIC INITIATIVES
8.4.10. LUMIPROBE CORPORATION
8.4.10.1. OVERVIEW
8.4.10.2. FINANCIAL PERFORMANCE
8.4.10.3. PRODUCT BENCHMARKING
8.4.10.4. STRATEGIC INITIATIVES
著作権 ©2022 無断複写・転載を禁じます